{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:36:43Z","timestamp":1773027403278,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/mph.0000000000000424","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T13:44:35Z","timestamp":1443620675000},"page":"e447-e452","source":"Crossref","is-referenced-by-count":25,"title":["Bleomycin-associated Lung Toxicity in Childhood Cancer Survivors"],"prefix":"10.1097","volume":"37","author":[{"given":"Alexandra P.","family":"Zorzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie L.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Dell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20221016","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/cncr.20910","article-title":"International classification of childhood cancer, third edition","volume":"103","author":"Steliarova-Foucher","year":"2005","journal-title":"Cancer"},{"key":"R2-13-20221016","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2013.6296","article-title":"Clinical ascertainment of health outcomes among adults treated for childhood cancer","volume":"309","author":"Hudson","year":"2013","journal-title":"JAMA"},{"key":"R3-13-20221016","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"R4-13-20221016","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/jnci\/djn310","article-title":"Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study","volume":"100","author":"Mertens","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R5-13-20221016","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1200\/JCO.2008.21.1516","article-title":"High-risk populations identified in childhood cancer survivor study investigations: implications for risk-based surveillance","volume":"27","author":"Hudson","year":"2009","journal-title":"J Clin Oncol"},{"key":"R6-13-20221016","first-page":"64","article-title":"Bleomycin pulmonary toxicity: current status and future directions","volume":"19","author":"Comis","year":"1992","journal-title":"Semin Oncol"},{"key":"R7-13-20221016","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.me.39.020188.002143","article-title":"Mechanisms of drug-induced pulmonary disease","volume":"39","author":"Cooper","year":"1988","journal-title":"Annu Rev Med"},{"key":"R8-13-20221016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-5231(21)00668-7","article-title":"Bleomycin-induced pulmonary toxicity","volume":"11","author":"Jules-Elysee","year":"1990","journal-title":"Clin Chest Med"},{"key":"R9-13-20221016","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/annonc\/mdg020","article-title":"Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours","volume":"14","author":"O\u2019Sullivan","year":"2003","journal-title":"Ann Oncol"},{"key":"R10-13-20221016","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1378\/chest.120.2.617","article-title":"Bleomycin-induced pneumonitis","volume":"120","author":"Sleijfer","year":"2001","journal-title":"Chest"},{"key":"R11-13-20221016","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1378\/chest.10-2133","article-title":"Pulmonary outcomes in survivors of childhood cancer: a systematic review","volume":"140","author":"Huang","year":"2011","journal-title":"Chest"},{"key":"R12-13-20221016","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/pbc.25098","article-title":"Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin","volume":"61","author":"De","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R13-13-20221016","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1200\/JCO.2004.11.032","article-title":"Development of risk-based guidelines for pediatric cancer survivors: the Children\u2019s Oncology Group Long-Term Follow-Up Guidelines from the Children\u2019s Oncology Group Late Effects Committee and Nursing Discipline","volume":"22","author":"Landier","year":"2004","journal-title":"J Clin Oncol"},{"key":"R14-13-20221016","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1200\/JCO.2012.43.4951","article-title":"Yield of screening for long-term complications using the children\u2019s oncology group long-term follow-up guidelines","volume":"30","author":"Landier","year":"2012","journal-title":"J Clin Oncol"},{"key":"R15-13-20221016","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/thoraxjnl-2011-200618","article-title":"Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer","volume":"66","author":"Mulder","year":"2011","journal-title":"Thorax"},{"key":"R16-13-20221016","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur Respir J"},{"key":"R17-13-20221016","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"R18-13-20221016","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1164\/rccm.200708-1248OC","article-title":"Reference ranges for spirometry across all ages: a new approach","volume":"177","author":"Stanojevic","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R19-13-20221016","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1183\/09031936.05.00035005","article-title":"Standardisation of the measurement of lung volumes","volume":"26","author":"Wanger","year":"2005","journal-title":"Eur Respir J"},{"key":"R20-13-20221016","first-page":"879","article-title":"Standards of pulmonary function in children","volume":"99","author":"Weng","year":"1969","journal-title":"Am Rev Respir Dis"},{"key":"R21-13-20221016","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1183\/09031936.05.00034905","article-title":"Standardisation of the single-breath determination of carbon monoxide uptake in the lung","volume":"26","author":"Macintyre","year":"2005","journal-title":"Eur Respir J"},{"key":"R22-13-20221016","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/cncr.10978","article-title":"Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study","volume":"95","author":"Mertens","year":"2002","journal-title":"Cancer"},{"key":"R23-13-20221016","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/1097-0142(19950401)75:7<1706::AID-CNCR2820750723>3.0.CO;2-T","article-title":"Serial pulmonary function studies in children treated for newly diagnosed Hodgkin\u2019s disease with mantle radiotherapy plus cycles of cyclophosphamide, vincristine, and procarbazine alternating with cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine","volume":"75","author":"Marina","year":"1995","journal-title":"Cancer"},{"key":"R24-13-20221016","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/(SICI)1096-911X(199804)30:4<240::AID-MPO6>3.0.CO;2-G","article-title":"Risk factors for reduced pulmonary function after malignant lymphoma in childhood","volume":"30","author":"Nysom","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"R25-13-20221016","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/pbc.21175","article-title":"Long-term pulmonary function in survivors of childhood Hodgkin disease and non-Hodgkin lymphoma","volume":"49","author":"Oguz","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R26-13-20221016","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pupt.2005.01.007","article-title":"Bleomycin lung toxicity: who are the patients with increased risk?","volume":"18","author":"Azambuja","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"R27-13-20221016","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00001622-200107000-00006","article-title":"Radiation-induced and chemotherapy-induced pulmonary injury","volume":"13","author":"Abid","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"R28-13-20221016","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9343(83)91009-4","article-title":"Pulmonary complications associated with combination chemotherapy programs containing bleomycin","volume":"74","author":"Bauer","year":"1983","journal-title":"Am J Med"},{"key":"R29-13-20221016","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/1097-0142(197605)37:5<2414::AID-CNCR2820370533>3.0.CO;2-J","article-title":"Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer","volume":"37","author":"Einhorn","year":"1976","journal-title":"Cancer"},{"key":"R30-13-20221016","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/pbc.20457","article-title":"Pulmonary function abnormalities in children treated with whole lung irradiation","volume":"46","author":"Weiner","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"R31-13-20221016","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0360-3016(89)90485-9","article-title":"Pediatric Hodgkin\u2019s disease: pulmonary, cardiac, and thyroid function following combined modality therapy","volume":"16","author":"Mefferd","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R32-13-20221016","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1001\/jama.239.19.2012","article-title":"Reversibility of severe bleomycin-induced pneumonitis","volume":"239","author":"Brown","year":"1978","journal-title":"JAMA"},{"key":"R33-13-20221016","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.bmt.1702154","article-title":"Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies","volume":"25","author":"Alessandrino","year":"2000","journal-title":"Bone Marrow Transplant"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201511000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T23:00:33Z","timestamp":1665961233000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201511000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000424","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}